Search

Your search keyword '"MESH: Polyethylene Glycols"' showing total 27 results

Search Constraints

Start Over You searched for: Descriptor "MESH: Polyethylene Glycols" Remove constraint Descriptor: "MESH: Polyethylene Glycols" Topic chemistry.chemical_compound Remove constraint Topic: chemistry.chemical_compound
27 results on '"MESH: Polyethylene Glycols"'

Search Results

1. Investigation of cationized triblock and diblock poly(ε-caprolactone)-co-poly(ethylene glycol) copolymers for oral delivery of enoxaparin: In vitro approach

2. Freeze drying of polyelectrolyte complex nanoparticles: Effect of nanoparticle composition and cryoprotectant selection

3. Poly ethylene glycol (PEG)-Related controllable and sustainable antidiabetic drug delivery systems

4. Self-aggregation of cationically modified poly( ε -caprolactone) 2 - co -poly(ethylene glycol) copolymers: Effect of cationic grafting ligand and poly( ε -caprolactone) chain length

5. Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection

6. Ribavirin in chronic hepatitis C: past and future

7. Water-Soluble Pegylated Quantum Dots: From a Composite Hexagonal Phase to Isolated Micelles

8. Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin

9. Factors that predict response of patients with hepatitis C virus infection to boceprevir

10. The treatment response of chronically hepatitis C virus-infected patients depends on interferon concentration but not on interferon gene expression in peripheral blood mononuclear cells

11. Sustained virological response after 14-day treatment with danoprevir and 48-week treatment with pegylated interferon-α2a (40 KD) plus ribavirin

12. Pharmacological exposure to ribavirin: a key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment

13. Toward characterizing seed vigor in alfalfa through proteomic analysis of germination and priming

14. New functional degradable and bio-compatible nanoparticles based on poly(malic acid) derivatives for site-specific anti-cancer drug delivery

15. Boceprevir for untreated chronic HCV genotype 1 infection

16. Gene transfer by histidylated lipopolyplexes: A dehydration method allowing preservation of their physicochemical parameters and transfection efficiency

17. Improvement of HepG2/C3a cell functions in a microfluidic biochip

18. Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study

19. Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic response

20. Ternary protein adsorption onto brushes: strong versus weak

21. Efficacy and safety of peginterferon alpha-2a/ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C

22. Behaviors of keratinocytes and fibroblasts on films of PLA50-PEO-PLA50 triblock copolymers with various PLA segment lengths

23. PEGylation of microspheres for therapeutic embolization: preparation, characterization and biological performance evaluation

24. Pluronic F68 block polymer, a very potent suppressor of carcinogenesis in the colon of rats and mice

25. Cytostatic effect of polyethylene glycol on human colonic adenocarcinoma cells

26. Oligonucleotide hybridisations on glass supports: a novel linker for oligonucleotide synthesis and hybridisation properties of oligonucleotides synthesised in situ

27. Lactotransferrin receptor of mouse small-intestinal brush border. Binding characteristics of membrane-bound and triton X-100-solubilized forms

Catalog

Books, media, physical & digital resources